Boehringer Ingelheim’s Alupent (metaproterenol)
Original formulation of the metered dose inhaler product, which contains sorbitan triolate as the suspension agent, is now available in pharmacies. The company had said in November ("The Pink Sheet" Nov. 6, T&G-16) that it planned to relaunch the product in the original formulation, after it withdrew stocks of a newer formulation following adverse reports from long-time users.
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”